611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Morphine Effects Similar to Placebo in Rheumatoid ArthritisHealth Tip: Learn Your Risk for AsthmaEczema Can Take a Toll on AdultsAOSSM: New Surgical Option for Irreparable Rotator Cuff TearsDrug Beats Steroids for Controlling Blood Vessel Inflammation in StudyNew Surgery May Fix Tough-to-Treat Rotator Cuff TearsNearly All Autopsied NFL Players Show Trauma-Linked Brain DiseaseMany Primary Care Docs May Miss PrediabetesIs the 'Anti-Statin' Trend Threatening Lives?Obese Don't Have to Lose Weight Before Joint Replacement: StudyDoes Your Child Really Have a Food Allergy?Health Tip: Adapting After Hip ReplacementHealth Tip: If Heartburn Doesn't Go AwayBlame Diabetes: Rates of 2 Nerve Conditions on the RiseSurgery for ACL Tear Often Successful Over Long TermEHR-Based Prompt Ups Hepatitis C Screening for Baby BoomersTravelers to Europe Need Measles Protection: CDCLaser Therapy Shows Promise Against Eye 'Floaters'Health Tip: Ease the Pain of a BlisterChronic Disease Risk Rises With Even Slow, Steady Weight GainAs Your Weight Creeps Up, So Does Your Risk of Heart FailureResearchers Grow Functioning Liver Tissue in MiceMore Than 100 Million Americans Have Diabetes or Prediabetes: CDCMeasles Outbreak Identified in Minnesota Is OngoingMore Evidence That Midlife Weight Gain Harms Your HealthReducing Repeat Hospitalizations Doesn't Harm Patients: StudyImpaired Eyesight May Be First Sign of Zika Damage in BabiesSome Medicines Boost Sensitivity to Sun9/11 Survivors More Likely to Have Heart, Lung DiseasesCould Artificial Sweeteners Raise Your Odds for Obesity?Many Americans Unaware of This Year's Heavy Tick Season: PollAfter Sunburn, High-Dose Vitamin D Cuts Inflammatory MediatorsHealth Tip: At Risk of Heat Illness?Working Too Much Might Tip Heart Into Irregular RhythmQuitting Smoking Can Bring Healthier Sinuses Years Later: StudyThyroid Problems May Make Things Worse for Dialysis PatientsWhite Collar Workers at Higher Odds of Death From ALS, Parkinson'sExperimental Vaccines Might Shield Fetus From ZikaStudy Spots Cause of Global Outbreak of Infections Tied to Heart SurgeriesEducation Can Boost Knowledge, Cut Anxiety in GlaucomaReview: Little Evidence on Vitamin D-Allergy AssociationClimate Change Delivers 'Double Whammy' to 4 in 10 AmericansHealth Tip: Battling Muscle Cramps?Too Few Children Get EpiPen When Needed: StudyCPAP Mask Not a Prescription for Heart TroublesNew Criteria Urged for Infection Diagnosis Among Seniors in EREarly Parkinson's May Prompt Vision ProblemsParkinson's Patients Deemed at Higher Risk of MelanomaViagra Might Make for a Safer, More Effective StentDaily Jolt of Java May Bring Longer Life
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Ischemic Outcomes Don't Vary With Gender in ACS Patients


HealthDay News
Updated: May 4th 2017

new article illustration

THURSDAY, May 4, 2017 (HealthDay News) -- For acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) and receiving clopidogrel, prasugrel, or ticagrelor, ischemic outcome does not differ by gender, according to a study published online April 29 in Cardiovascular Therapeutics.

Ioanna Xanthopoulou, M.D., from Patras University Hospital in Greece, and colleagues examined sex-based differences in ACS patients undergoing PCI and receiving clopidogrel, prasugrel, or ticagrelor. A total of 2,047 patients were recruited and followed for one year. The authors recorded major adverse cardiovascular events (MACE) and bleeding events (Bleeding Academic Research Consortium [BARC] classification).

The researchers found that clopidogrel was more frequently administered to women at PCI hospitalization and at discharge. MACE occurred in 9.2 percent of women and 8.1 percent of men, with no significant difference by gender. In women and men, the rate of observed bleeding of BARC any type was 57.2 and 44.4 percent, respectively. Differences in BARC any type and BARC type 1 events remained significant following adjustment, with higher rates seen for women (hazard ratios, 1.51 and 1.58, respectively; both P < 0.001)

"In a contemporary 'real life' cohort of ACS patients treated with PCI and focusing on antiplatelet treatment there are demographic, clinical, procedural, and treatment differences between sexes," the authors write. "One-year ischemic outcome does not differ by gender, while women do present more frequently [with] bleeding events."

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)